VCYT

Veracyte, Inc. VCYT

VCYT
Veracyte, Inc. IDYA
IDEAYA Biosciences, Inc. SNDX
Syndax Pharmaceuticals, Inc. XNCR
Xencor, Inc. RGNX
REGENXBIO Inc. CRNX
Crinetics Pharmaceuticals, Inc. CDNA
CareDx, Inc TWST
Twist Bioscience Corporation IOVA
Iovance Biotherapeutics, Inc. FATE
Fate Therapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode VCYT IDYA SNDX XNCR RGNX CRNX CDNA TWST IOVA FATE
6M 9.43 % 56.66 % 43.91 % 52.58 % 85.40 % 54.35 % -23.50 % -19.72 % -36.36 % 54.25 %
YTD -13.95 % 4.29 % 14.06 % -45.23 % 38.93 % -12.84 % -33.13 % -31.16 % -73.04 % -8.66 %
1Y 2.56 % -13.88 % -18.97 % -38.04 % 7.06 % -15.39 % -54.04 % -33.13 % -78.51 % -46.39 %
3Y 118.73 % 66.82 % -33.94 % -50.87 % -51.38 % 151.71 % -16.14 % 2.40 % -77.20 % -92.33 %
5Y -16.75 % 87.43 % 3.95 % -68.83 % -63.21 % 177.86 % -72.61 % -65.47 % -93.24 % -96.65 %
10Y 471.43 % 134.50 % 33.83 % 9.31 % -43.36 % 83.31 % 216.26 % 122.79 % -66.51 % -68.19 %
From the beginning 162.64 % 134.50 % 33.83 % 56.24 % -64.14 % 83.31 % 59.01 % 122.79 % -98.09 % -75.30 %

Dividend